BILLERICA, Mass., Sept. 5, 2017 /PRNewswire/ -- Bruker Corporation (NASDAQ: BRKR) announced today it will present at the 15th Annual Morgan Stanley Global Healthcare Conference. Juergen Srega, President of the Bruker CALID Group, will participate in a "fireside chat" Q&A session on behalf of the company on Monday, September 11th, 2017 at 1:40 PM Eastern Time.  

A live audio webcast of the presentation will be available on the Investor section of the Company's website at http://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation website after the event and will be available for 30 days following the presentation.

About Bruker Corporation

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life.  Bruker's high-performance scientific instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.  In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nanoanalysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics.  For more information, please visit: www.bruker.com.  

Contact
Miroslava Minkova
Head of Investor Relations 
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479  
miroslava.minkova@bruker.com                                                           

View original content:http://www.prnewswire.com/news-releases/bruker-corporation-to-present-at-the-15th-annual-morgan-stanley-global-healthcare-conference-300514057.html

SOURCE Bruker Corporation

Copyright 2017 PR Newswire

Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bruker Charts.
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bruker Charts.